← Holders
Siren, L.L.C.
What Siren, L.L.C. reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 2005245 · Filed Nov 12, 2026
- Positions
- 111
- Reported value
- $4.2B
- Opened
- 18
- Closed
- 24
- Other managers included
- 2
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$2.6B115 positions
- Dec 31, 2025$3.4B113 positions
- Mar 31, 2026$3.6B100 positions
- Jun 30, 2026$4.9B117 positions
- Sep 30, 2026$4.2B111 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
SRRKScholar Rock Holding Corp | 9.4M | −2.1% | $453M | 10.7% |
KYMRKymera Therapeutics, Inc. | 2.8M | −5.1% | $311.3M | 7.4% |
ERASErasca, Inc. | 13.2M | +15.8% | $193.5M | 4.6% |
RVMDRevolution Medicines, Inc. | 850K | −5.6% | $174.5M | 4.1% |
ONCBeOne Medicines Ltd. | 465K | ±0% | $170.2M | 4% |
TNGXTango Therapeutics, Inc. | 6.8M | +9.8% | $169.3M | 4% |
MANEVeradermics, Inc | 1.3M | −20.0% | $160.5M | 3.8% |
ARWRArrowhead Pharmaceuticals, Inc. | 2.3M | +33.5% | $149.9M | 3.5% |
EWTXEdgewise Therapeutics, Inc. | 2.8M | −11.9% | $113.8M | 2.7% |
RYTMRhythm Pharmaceuticals, Inc. | 1.1M | −4.4% | $103.4M | 2.4% |
BCAXBicara Therapeutics Inc. | 5.5M | −1.8% | $102.4M | 2.4% |
PBLSParabilis Medicines, Inc. | 3M | ±0% | $96.6M | 2.3% |
LXRXLexicon Pharmaceuticals, Inc. | 44.3M | ±0% | $83.3M | 2% |
SYRESpyre Therapeutics, Inc. | 868.6K | −10.3% | $77.3M | 1.8% |
TYRATyra Biosciences, Inc. | 3.4M | +368.4% | $74.3M | 1.8% |
COAGHemab Therapeutics Holdings, Inc. | 2.4M | +13.4% | $73M | 1.7% |
AMLXAmylyx Pharmaceuticals, Inc. | 2.5M | +67.5% | $72.2M | 1.7% |
ELVNEnliven Therapeutics, Inc. | 1.5M | −16.9% | $67.6M | 1.6% |
SEPNSepterna, Inc. | 1.7M | −10.5% | $66.5M | 1.6% |
RCUSArcus Biosciences, Inc. | 2.4M | ±0% | $62.5M | 1.5% |
RLAYRelay Therapeutics, Inc. | 3.3M | −10.6% | $58.9M | 1.4% |
IRONDisc Medicine, Inc. | 888.4K | ±0% | $58.2M | 1.4% |
SLDBSolid Biosciences Inc. | 7.7M | ±0% | $55.6M | 1.3% |
STOKStoke Therapeutics, Inc. | 2M | ±0% | $51.9M | 1.2% |
COGTCogent Biosciences, Inc. | 1.6M | −13.4% | $51.5M | 1.2% |
TSHATaysha Gene Therapies, Inc. | 9.8M | ±0% | $48M | 1.1% |
CYTKCytokinetics Inc | 709K | −6.6% | $46.7M | 1.1% |
ORICOric Pharmaceuticals, Inc. | 3.4M | +12.0% | $45.2M | 1.1% |
OLMAOlema Oncology, Inc. | 4.9M | ±0% | $42M | 1% |
DYNDyne Therapeutics, Inc. | 2.4M | +14.1% | $39.1M | 0.9% |
ADRXADARx Pharmaceuticals, Inc. | 1.9M | New | $38.4M | 0.9% |
RELYRemitly Global, Inc. | 1.5M | ±0% | $32.9M | 0.8% |
SLNSilence Therapeutics plc | 2.9M | −12.8% | $31.6M | 0.7% |
ASNDAscendis Pharma A/S | 130K | New | $29.6M | 0.7% |
DNLIDenali Therapeutics Inc. | 1.4M | ±0% | $28.9M | 0.7% |
PVLAPalvella Therapeutics, Inc. | 207.5K | −19.4% | $28.6M | 0.7% |
DBVTDBV Technologies S.A. | 2.4M | +26.9% | $27.7M | 0.7% |
CGEMCullinan Therapeutics, Inc. | 1.8M | −5.3% | $27.5M | 0.7% |
GOOGLAlphabet Inc. | 80K | −11.1% | $27.5M | 0.7% |
GPCRStructure Therapeutics Inc. | 873K | ±0% | $27.3M | 0.6% |
XENEXenon Pharmaceuticals Inc. | 718.3K | −45.5% | $26.7M | 0.6% |
KLRAKailera Therapeutics, Inc. | 2.2M | ±0% | $25.3M | 0.6% |
AGENAgenus Inc | 2.4M | +127.3% | $24M | 0.6% |
NVDANVIDIA Corp | 97.5K | +2.6% | $22.3M | 0.5% |
SPTXSeaport Therapeutics, Inc. | 1.1M | ±0% | $22.1M | 0.5% |
TRVITrevi Therapeutics, Inc. | 1.5M | −14.7% | $21.8M | 0.5% |
RAPPRapport Therapeutics, Inc. | 641.5K | ±0% | $21.6M | 0.5% |
MNPRMonopar Therapeutics | 270.1K | ±0% | $21.5M | 0.5% |
TSMTaiwan Semiconductor Manufacturing Co Ltd | 45K | +0.7% | $20.5M | 0.5% |
DMRADamora Therapeutics, Inc. | 900K | New | $19.2M | 0.5% |
ABVXAbivax S.A. | 188K | −67.4% | $18.6M | 0.4% |
ANNXAnnexon, Inc. | 4.4M | −2.2% | $18.4M | 0.4% |
ENTXEntera Bio Ltd. | 6M | +714.7% | $17.5M | 0.4% |
MSFTMicrosoft Corp | 34K | −9.3% | $17.4M | 0.4% |
ZURAZura Bio Ltd | 3.7M | ±0% | $15.5M | 0.4% |
YARWYarrow Bioscience, Inc. | 675K | New | $15.2M | 0.4% |
ABSIAbsci Corp | 1.4M | −44.4% | $14.8M | 0.3% |
SKHYSK hynix Inc. | 80K | New | $14.7M | 0.3% |
TBLATaboola.com Ltd. | 4.3M | −49.4% | $14.3M | 0.3% |
GHRSGH Research PLC | 600K | New | $14.1M | 0.3% |
RZLTRezolute, Inc. | 3.3M | ±0% | $13.8M | 0.3% |
ENGNenGene Therapeutics Inc. | 6.3M | ±0% | $12.5M | 0.3% |
| 24K | ±0% | $12.3M | 0.3% | |
NOWServiceNow, Inc. | 90K | −10.0% | $12.1M | 0.3% |
IKTInhibikase Therapeutics, Inc. | 5.9M | ±0% | $12M | 0.3% |
NBISNebius Group N.V. | 47.5K | −8.7% | $11.2M | 0.3% |
GENBGenerate Biomedicines, Inc. | 736.1K | ±0% | $11.1M | 0.3% |
DTDynatrace, Inc. | 190K | +22.6% | $11M | 0.3% |
ACRSAclaris Therapeutics, Inc. | 2M | New | $10.7M | 0.3% |
AVGOBroadcom Inc. | 29.5K | +18.0% | $10.4M | 0.2% |
CTMXCytomX Therapeutics, Inc. | 3.5M | ±0% | $9.4M | 0.2% |
WHWKWhitehawk Therapeutics, Inc. | 2.3M | ±0% | $8.8M | 0.2% |
MSLESatellos Bioscience Inc. | 892.1K | ±0% | $7.6M | 0.2% |
IONQIonQ, Inc. | 170K | ±0% | $7.5M | 0.2% |
DSGNDesign Therapeutics, Inc. | 523.2K | ±0% | $6.6M | 0.2% |
FROGJFrog Ltd | 66.5K | −30.4% | $6.5M | 0.2% |
ELOXEloxx Pharmaceuticals, Inc. | 400K | ±0% | $6.1M | 0.1% |
OCSOculis Holding AG | 625K | ±0% | $5.8M | 0.1% |
CBIOCrescent Biopharma, Inc. | 400K | New | $5.8M | 0.1% |
AMZNAmazon Com Inc | 21.5K | −33.8% | $5.4M | 0.1% |
CRWDCrowdStrike Holdings, Inc. | 20K | +100.0% | $5.3M | 0.1% |
NMRANeumora Therapeutics, Inc. | 8.5M | ±0% | $5.1M | 0.1% |
VTVTvTv Therapeutics Inc. | 163K | ±0% | $5M | 0.1% |
DDOGDatadog, Inc. | 18K | −55.0% | $4.9M | 0.1% |
AGMBAgomAb Therapeutics NV | 411.3K | ±0% | $4.6M | 0.1% |
ODTXOdyssey Therapeutics, Inc. | 200K | ±0% | $4.4M | 0.1% |
IVVDInvivyd, Inc. | 5M | ±0% | $4.4M | 0.1% |
JMKEJersey Mike's Subs Inc. | 250K | New | $4.2M | 0.1% |
IRENIren Ltd | 100K | −42.9% | $4.1M | 0.1% |
OUSTOuster, Inc. | 100K | +48.1% | $4M | 0.1% |
WSEWise Group plc | 350.9K | New | $4M | 0.1% |
TTMITTM Technologies Inc | 30K | New | $3.7M | 0.1% |
KRROKorro Bio, Inc. | 347.7K | ±0% | $3.4M | 0.1% |
MNDYmonday.com Ltd. | 37.5K | −11.8% | $2.9M | 0.1% |
AEVAAeva Technologies, Inc. | 200K | +37.5% | $2.8M | 0.1% |
ASAmer Sports, Inc. | 100K | New | $2.7M | 0.1% |
PALIPalisade Bio, Inc. | 2M | ±0% | $2.7M | 0.1% |
FHTXFoghorn Therapeutics Inc. | 720.7K | ±0% | $2.6M | 0.1% |
GTLBGitlab Inc. | 50K | −60.0% | $2.4M | 0.1% |
BACBank of America Corp | 40K | New | $2.2M | 0.1% |
SCHWSchwab Charles Corp | 15K | New | $1.5M | 0.1% |
FANGDiamondback Energy, Inc. | 7.5K | New | $1.4M | 0.1% |
ADAGAdagene Inc. | 421.7K | −84.2% | $1.3M | 0.1% |
MGMMGM Resorts International | 43K | New | $1.3M | 0.1% |
RANIRani Therapeutics Holdings, Inc. | 1.6M | −20.3% | $1.3M | 0.1% |
FIGFigma, Inc. | 50K | ±0% | $1.1M | 0.1% |
KLRSKalaris Therapeutics, Inc. | 356.6K | −18.2% | $1M | 0.1% |
QNTQuantinuum Inc. | 20K | ±0% | $961.2K | 0.1% |
ZTSZoetis Inc. | 12.5K | −64.3% | $872.9K | 0.1% |
GOSSGossamer Bio, Inc. | 65.1K | New | $771.6K | 0.1% |
PRMBPrimo Brands Corp | 25K | New | $476.3K | 0.1% |